HAEMONETICS CORP — Director's Dealing 2015

Jul 21, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-04-27

Reporting Person: Selman Byron (President, Global Markets)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6993	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$34.745	2021-10-22	Common Stock (10376)		Direct
Non-Qualified Stock Option (right to buy)	$39.055	2019-10-24	Common Stock (22676)		Direct
Non-Qualified Stock Option (right to buy)	$41.66	2020-10-23	Common Stock (16778)		Direct
Performance Shares	$0.0	2017-12-30	Common Stock (12500)		Direct
Performance Shares	$0.0	2017-12-31	Common Stock (11226)		Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.